Tag Archives: Wellcome Trust

Lying Corporatist dog W.H.O. to Declare New Ebola Emergency

The BBC reports the following:
Ebola outbreak: Grandmother dies in Uganda after DR Congo
Today according to the BBC, the World Health Organization (WHO) will decide if the “outbreak” in DR Congo should now be deemed a global health emergency.

We have Dr Jeremy Farrar, the director of the Wellcome Trust, stating it shows “no sign of stopping”.
How did they verify that all 1400 people died of Ebola as they claim? Their golden new test, PCR?
Well, Jon Rappoport has done an excellent job of  exposing the flawed logic of this PCR test. The gold standard of medical tests is fake

If all you can find is a tiny, tiny fragment of what might be a virus, you already know you’re barking up the wrong tree.

Without the PCR, you should be able to establish that millions of a particular virus have invaded the patient’s body.

If you can’t, why bother using the PCR?

We contrast the claim of 1400 Ebola “deaths” with the estimated 4-5 thousand dead between 2016 and 2017 due to the resource confict in the area. How many have died since the resource conflicts began? Estimates are disputed but they all agree on the magnitude. 3 million? 5 million? 7 million? Millions have died.

We can clearly debunk the pretence to care for the well-being of Africans in DR Congo or East Africa.

Furthermore there is another dirty little secret that the lying, murderous, profiteering global medical cartel are hiding. Hemorrhagic viruses induce acute scurvy. What is the cure for scurvy? Vitamin C.
https://vitamincfoundation.org/www.orthomed.com/ebola.htm

Nurse Pineo, the first white that survived the Lassa fever (another hemorrhagic fever) outbreak in Lassa, was, on her own, taking vitamins (Fuller, JG. Fever. Reader’s Digest Press. 1974.) Of course that was ignored and they used her convalescent serum for subsequent cases of Lassa fever in medical personnel. Why not give subsequent cases vitamins also? Maybe especially massive doses of vitamin C – to prevent the acute induced scurvy.

Because there is a breakdown of the blood vessels, it might be helpful to give a couple of grams of bioflavonoids and a multiple vitamin every day. Oh! but I forgot, these are not patentable so not profitable to the drug industry.

So, we await the W.H.O.re declaring a new Ebola Emergency to push their patented vaccines. The numbers of deaths are suspect, their claim to care is a lie and their solution – vaccines- another filthy lie.

Advertisements

Experimental Ebola vaccine shipped to Liberia

http://www.theguardian.com/world/2015/jan/23/ebola-vaccine-liberia-gsk-glaxosmithkline-trials

GSK hopes to enrol 30,000 people in first large-scale trials of the vaccine, which uses a type of chimpanzee cold virus

Dr Jeremy Farrar, director of the Wellcome Trust, which is funding a trial of the vaccine in UK and Mali and parallel studies of other vaccines in Geneva, Gabon, Kenya and Guinea, said: “This week we’ve heard encouraging news from west Africa, indicating that we may at last have reached a turning point in what has been the worst Ebola outbreak in history. Mali has been declared free from the disease and schools in Guinea reopened, restoring some sense of normality for those communities.

Ebola treatment trials to be fast-tracked in West Africa

http://www.wellcome.ac.uk/News/Media-office/Press-releases/2014/WTP057419.htm

A £3.2 million grant from the Wellcome Trust will enable multiple partners around the world to quickly establish clinical trials at existing Ebola treatment centres. Partners include the International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC), the University of Oxford, Médecins Sans Frontières (MSF), the World Health Organization (WHO), Institut Pasteur, Institut Pasteur de Dakar, Fondation Mérieux and the Global Health Network.

In August a WHO expert panel unanimously concluded that in such exceptional circumstances it would be ethical to evaluate unregistered investigational treatments in people with Ebola virus disease.

Several potential interventions have shown promise in the laboratory, in animal studies on non-human primates, and in a small number of cases of compassionate intervention, but none has yet been tested for efficacy and safety in humans with Ebola. Any new drug needs to be evaluated within the rigorous settings of a clinical trial to assess whether it is doing more harm or good.

The belief system of the global medical system cannot entertain the simpler solutions. We can with high confidence state, that Intravenous Vitamin C, collodial/nano silver and natural antiviral oils would be safer as treatment protocols and would provide the validation of these solutions that these medical priests state they seek for corporate “unregistered investigational treatment”.
Further evidence of the collusion of academia and funding foundations in the fraud that are vaccines.

New 15-minute test for Ebola to be trialled in Guinea

http://www.wellcome.ac.uk/News/Media-office/Press-releases/2014/WTP058046.htm

The 15-minute Ebola test is six times faster than similar tests currently in use and aims to speed up the diagnosis of Ebola cases. Early detection of Ebola leads to better infection control as medical staff can identify and isolate confirmed cases of Ebola faster, and start treating patients sooner. Ultimately, a faster test could reduce Ebola transmission and mortality.

The project is supported through a joint Department for International Development (DFID) and Wellcome Trust fund for rapid health research during the Ebola outbreak. The six projects are managed by Enhancing Learning & Research for Humanitarian Assistance (ELRHA).

The trial, led by researchers at the Pasteur Institute in Dakar, Senegal, will be deployed using a ‘mobile suitcase laboratory’ which is designed for low-resource settings. The portable laboratory includes a solar panel, a power pack and a results reader which is the size of a small laptop.

The reagents used in the test are available as dried pellets, which are ‘cold-chain-independent’, meaning that they can be used and transported at room temperature. Similarly to the tests currently in use, the new test detects the genetic material of the virus. The pilot trial will test whether the reagents are safe and effective to use with Ebola patients’ blood and saliva samples…